AREV Life Sciences Global Corp (AREVF)
AREV Life Sciences Global Corp operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Coquitlam, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $15,881. On trailing twelve-month figures it carries a trailing P/E of -1.87, a net margin of -2940.4%. Its beta of 4.94 implies it has historically moved more than the broad market.
AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company's pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES-TORE, a product based on organic plant nutrition for patients with overt clinical need for rational enhanced caloric intake and micronutrient supplementation. It also develops edible oils, moringa, hops, cannabis sativa, pharma, sea cucumber, ginseng, and functional fungi ingredients; and anti-virals and phytomedicinalization. In addition, the company flash-freezes active ingredients, oils, and oleoresins for use as ingredients in food, nutraceuticals, and other consumer products. The company was formerly known as AREV NanoTec Brands Inc. and changed its name to AREV Life Sciences Global Corp. in August 2021. AREV Life Sciences Global Corp. is based in Coquitlam, Canada.
AREV Life Sciences Global Corp is most often compared with the following Healthcare names: